The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Radacef     (6R,7S)-7-[2-[2- (aminomethyl)phenyl]ethano...

Synonyms: CEFORANIDE, Ceforanido, Precef, Ceforanidum, BL-S786, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CEFORANIDE

 

High impact information on CEFORANIDE

 

Chemical compound and disease context of CEFORANIDE

 

Biological context of CEFORANIDE

 

Anatomical context of CEFORANIDE

 

Associations of CEFORANIDE with other chemical compounds

 

Gene context of CEFORANIDE

 

Analytical, diagnostic and therapeutic context of CEFORANIDE

References

  1. Ceforanide kinetics in renal insufficiency. Hawkins, S.S., Alford, R.H., Stone, W.J., Smyth, R.D., Pfeffer, M. Clin. Pharmacol. Ther. (1981) [Pubmed]
  2. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum. Barry, A.L., Jones, R.N., Packer, R.R. Antimicrob. Agents Chemother. (1986) [Pubmed]
  3. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Cooper, R.H., Savitch, C.B., Joseph, W.P., Mills, J. Antimicrob. Agents Chemother. (1981) [Pubmed]
  4. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial. Wallace, R.J., Martin, R.R., Quinones, F.J., Greenberg, S.B. Antimicrob. Agents Chemother. (1981) [Pubmed]
  5. Treatment of cellulitis with ceforanide. Musher, D.M., Fainstein, V., Young, E.J. Antimicrob. Agents Chemother. (1980) [Pubmed]
  6. Antibiotic prophylaxis for cardiovascular surgery. Efficacy with coronary artery bypass. Platt, R., Muñoz, A., Stella, J., VanDevanter, S., Koster, J.K. Ann. Intern. Med. (1984) [Pubmed]
  7. Ceforanide kinetics. Estey, E.H., Weaver, S.S., LeBlanc, B.M., Brown, N., Ho, D.H., Bodey, G.P. Clin. Pharmacol. Ther. (1981) [Pubmed]
  8. Intraoperative ceforanide pharmacokinetics and protein binding. DiPiro, J.T., Bayoumi, S.M., Vallner, J.J., Nesbit, R.R., Gokhale, R., Rissing, J.P. Antimicrob. Agents Chemother. (1985) [Pubmed]
  9. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Greenman, R.L., Arcey, S.M., Gutterman, D.A., Zweig, R.M. Antimicrob. Agents Chemother. (1984) [Pubmed]
  10. Treatment of scleroma with ceforanide. Cone, L.A., Barton, S.M., Woodard, D.R. Arch. Otolaryngol. Head Neck Surg. (1987) [Pubmed]
  11. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Tartaglione, T.A., Polk, R.E. Drug intelligence & clinical pharmacy. (1985) [Pubmed]
  12. An in vitro model for assessing muscle irritation due to parenteral antibiotics. Williams, P.D., Masters, B.G., Evans, L.D., Laska, D.A., Hottendorf, G.H. Fundamental and applied toxicology : official journal of the Society of Toxicology. (1987) [Pubmed]
  13. Pharmacokinetics of ceforanide. Ripa, S., La Rosa, F., Ghezzi, A., Prenna, M., Pfeffer, M. Antimicrob. Agents Chemother. (1982) [Pubmed]
  14. Comparison of cephalothin and ceforanide prophylaxis in cardiac surgery with cardiopulmonary bypass. Karney, W., Correa-Coronas, R., Zajtchuk, R., Schwartz, J., Smith, L.P., Tramont, E. Antimicrob. Agents Chemother. (1983) [Pubmed]
  15. Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery. Mullany, L.D., French, M.A., Nightingale, C.H., Low, H.B., Ellison, L.H., Quintiliani, R. Antimicrob. Agents Chemother. (1982) [Pubmed]
  16. Biliary levels of ceforanide. Kenady, D.E., Ram, M.D. Antimicrob. Agents Chemother. (1983) [Pubmed]
  17. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans. Lee, F.H., Pfeffer, M., Van Harken, D.R., Smyth, R.D., Hottendorf, G.H. Antimicrob. Agents Chemother. (1980) [Pubmed]
  18. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies. Weaver, S.S., LeBlanc, B.M., Bodey, G.P. Antimicrob. Agents Chemother. (1979) [Pubmed]
  19. Failure of probenecid to alter the pharmacokinetics of ceforanide. Jovanovich, J.F., Saravolatz, L.D., Burch, K., Pohlod, D.J. Antimicrob. Agents Chemother. (1981) [Pubmed]
  20. Comparison of intravenous administration with intrauterine irrigation with ceforanide for nonelective cesarean section. Saravolatz, L.D., Lee, C., Drukker, B. Obstetrics and gynecology. (1985) [Pubmed]
  21. Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages. Crowle, A.J., Sbarbaro, J.A., May, M.H. Tubercle. (1988) [Pubmed]
  22. In vitro and clinical evaluation of ceforanide. Lefrock, J.L., Holloway, W., Carr, B.B., Schell, R.F. Am. J. Med. Sci. (1984) [Pubmed]
  23. Efficacy and safety of ceforanide in the treatment of childhood infections. Thirumoorthi, M.C., Buckley, J.A., Vincent, C.V., Kobos, D., Dajani, A.S. Pediatric infectious disease. (1983) [Pubmed]
  24. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Campoli-Richards, D.M., Lackner, T.E., Monk, J.P. Drugs (1987) [Pubmed]
  25. Comparison of ceforanide and cephalothin prophylaxis for vaginal hysterectomies. Jacobson, J.A., Hebertson, R., Kasworm, E. Antimicrob. Agents Chemother. (1982) [Pubmed]
 
WikiGenes - Universities